References

1. Data on file. A randomized pilot study to compare the safety and efficacy of Promiseb Topical Cream and desonide cream 0.05% in the treatment of mild to moderate seborrheic dermatitis of the face. Promius Pharma, LLC: Bridgewater, NJ; 2008. PSC0801.

2. Bikowski J. Facial seborrheic dermatitis: a report on current status and therapeutic horizons. J Drugs Dermatol. 2009;8(2):125-133.

3. Data on file. An open-label, single-center, pilot study to determine the antifungal activity of Promiseb Topical Cream after seven days of use in normal volunteers. Promius Pharma, LLC: Bridgewater, NJ; 2008. PSC0802.

4. Data on file. Evaluation of Promiseb Topical Cream in the guinea pig model of M furfur infection. Promius Pharma, LLC: Bridgewater, NJ; 2009.

5. Data on file. A multicenter pilot clinical study to evaluate the efficacy and safety of Promiseb in the management of mild to moderate seborrhoeic dermatitis in adults. Surrey, United Kingdom: Sinclair Pharmaceuticals, LTD; 2006.

6. Churchill M. Seborrheic dermatitis FAQs. Geocities Web site.
http://www.geocities.com/mall_lago/. Accessed January 12, 2009.

7. American Academy of Dermatology. Seborrheic dermatitis. http://www.aad.org/public/publications/pamphlets/common_seb_dermatitis.html. Accessed January 12, 2009.

8. The British Skin Foundation. Seborrhoeic dermatitis. http://www.britishskinfoundation.org.uk/standard.aspx?id=172. Accessed January 27, 2009.

9. Mayo Clinic Web site. Seborrheic dermatitis.
http://www.mayoclinic.com/health/seborrheicdermatitis/DS00984. Accessed January 20, 2009.

10. Peyrí J, Lleonart M; Spanish group of the SEBDERM
study. Clinical and therapeutic profile and quality of life of patients with seborrheic dermatitis [in Spanish]. Actas Dermosifiliogr. 2007;98(7):476-482.

11. Del Rosso JQ. Treating seborrheic dermatitis. Skin & Aging. 2005;13(2). http://www.skinandaging.com/article/3675. Accessed January 15, 2009.

12. Promiseb™ [Package insert]. Promius Pharma, LLC: Bridgewater, NJ; 2009.